Response to Tinospora cordifolia (Giloy)-induced liver injury during the COVID-19 pandemic-Multicenter nationwide study from India

Affiliations

Multicenter Study

Geethalayam G Gangadharan et al. Hepatol Commun. 2022 Oct.

. 2022 Oct;6(10):2993-2994.

doi: 10.1002/hep4.1986. Epub 2022 May 26.

No abstract available

Conflict of interest statement

The authors have nothing to report.

Tinospora Cordifolia (Giloy)-Induced Liver Injury During the COVID-19 Pandemic-Multicenter Nationwide Study From India.
Kulkarni AV, Hanchanale P, Prakash V, Kalal C, Sharma M, Kumar K, Bishnu S, Kulkarni AV, Anand L, Patwa AK, Kumbar S, Kainth S, Philips CA; Liver Research Club India. Kulkarni AV, et al. Hepatol Commun. 2022 Jun;6(6):1289-1300. doi: 10.1002/hep4.1904. Epub 2022 Feb 6. Hepatol Commun. 2022. PMID: 35037744 Free PMC article.

1. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C, CONSORT Group . Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration. J Clin Epidemiol. 2006;59:1134–49. - PubMed
1. Wang JB, Zhu Y, Bai ZF, Wang FS, Li XH, Xiao XH, Branch Committee of Hepatobiliary Diseases and Branch Committee of Chinese Patent Medicines, China Association of Chinese Medicine . Guidelines for the diagnosis and management of herb‐induced liver injury. Chin J Integr Med. 2018. Sep;24:696–706. - PubMed
1. Lin NH, Yang HW, Su YJ, Chang CW. Herb induced liver injury after using herbal medicine: a systemic review and case‐control study. Medicine (Baltimore). 2019;98:e14992. - PMC - PubMed
1. Liu X, Jiang X, Liu R, Wang L, Qian T, Zheng Y, et al. B cells expressing CD11b effectively inhibit CD4+ T‐cell responses and ameliorate experimental autoimmune hepatitis in mice. Hepatology. 2015;62:1563–75. - PubMed